SIC 2835 – In Vitro and In Vivo Diagnostic Substances
Valuation | |
---|---|
Market Cap ($M) | 150.37 |
Enterprise Value ($M) | 151.49 |
Book Value ($M) | -1.45 |
Book Value / Share | -0.04 |
Price / Book | -103.84 |
NCAV ($M) | -3.84 |
NCAV / Share | -0.11 |
Price / NCAV | -39.19 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.95 |
Return on Assets (ROA) | -1.43 |
Return on Equity (ROE) | -67.30 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.82 |
Current Ratio | 0.82 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 16.98 |
Assets | 19.37 |
Liabilities | 20.82 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -27.25 |
Net Income | -29.82 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -24.48 |
Cash from Investing | -0.02 |
Cash from Financing | 15.28 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Franklin Resources Inc | 12.00 | ||
13G | Callahan Patrick J. III | 9.90 | ||
13G/A | Contrarian Alpha, LP | 9.70 | ||
13G | Dialectic Capital Management, Lp | 19.99 | 1.24 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 2054916.7 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
26,847 | 429,102 | 6.26 | |
10,265 | 62,109 | 16.53 | |
3,016 | 15,734 | 19.17 | |
11,356 | 16,466 | 68.97 | |
(click for more detail) |
Similar Companies | |
---|---|
ABIO – ARCA biopharma, Inc. | ABVC – ABVC BioPharma, Inc. |
ACB – Aurora Cannabis Inc. | ACST – Acasti Pharma Inc. |
ACXP – Acurx Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io